DAUNORUBICIN OR DOXORUBICIN IN ACUTE MYELOGENOUS LEUKEMIA

被引：0
|
作者：
GALE, RP
FOON, KA
机构：
[1] SUNY BUFFALO, DEPT MED, DIV CLIN IMMUNOL, BUFFALO, NY 14260 USA
[2] NEW YORK STATE DEPT HLTH, ROSWELL PK MEM INST, BUFFALO, NY 14263 USA
[3] UNIV CALIF LOS ANGELES, DEPT MED, DIV HEMATOL & ONCOL, LOS ANGELES, CA 90024 USA
来源：
LEUKEMIA | 1988年 / 2卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [1] ACQUIRED-RESISTANCE TO DAUNORUBICIN IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA
    SMITH, BJ
    KUNDU, D
    BRITISH JOURNAL OF CANCER, 1976, 34 (01) : 53 - 57
  • [2] Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine
    Sitar, Daniel S.
    Aoki, Fred Y.
    Bow, Eric J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (08): : 995 - 998
  • [3] COMBINATION DAUNORUBICIN-PREDNISONE TREATMENT OF ADULT ACUTE MYELOGENOUS LEUKEMIA
    BLOOMFIE.CD
    BRUNNING, RD
    THEOLOGI.A
    KENNEDY, BJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1972, 13 (MAR): : 36 - &
  • [4] In vitro cytotoxicity of the LDE:daunorubicin complex in acute myelogenous leukemia blast cells
    Dorlhiac-Llacer, PE
    Marquezini, MV
    Toffoletto, O
    Carneiro, RCG
    Maranhao, RC
    Chamone, DAF
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2001, 34 (10) : 1257 - 1263
  • [5] Infusional etoposide, daunorubicin, vincristine, and cytarabine in relapsed acute myelogenous leukemia.
    Walker, B
    Elkins, S
    Bigelow, C
    Files, J
    JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (01) : S289 - S289
  • [6] INFLUENCE OF DAUNORUBICIN AND CYTARABINE SEQUENCING ON THE OUTCOME OF THERAPY IN ACUTE MYELOGENOUS LEUKEMIA - A RANDOMIZED TRIAL
    ARCHIMBAUD, E
    FIERE, D
    TREILLERITOUET, D
    ADELEINE, P
    GUYOTAT, D
    SEBBAN, C
    VUVAN, H
    VIALA, JJ
    CANCER TREATMENT REPORTS, 1987, 71 (06): : 571 - 574
  • [7] HIGH DOSE DAUNORUBICIN (NSC-83142) IN TREATMENT OF ADVANCED ACUTE MYELOGENOUS LEUKEMIA
    LIPPMAN, M
    ZAGER, R
    HENDERSON, ES
    CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (06): : 755 - 760
  • [8] SUCCESSFUL RE-INDUCTION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA WITH CYTOSINE-ARABINOSIDE AND DAUNORUBICIN
    STEIN, RS
    FLEXNER, JM
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 2123 - 2124
  • [9] IN-VITRO CYTOTOXICITY OF MITOXANTRONE, DAUNORUBICIN AND DOXORUBICIN IN UNTREATED CHILDHOOD ACUTE-LEUKEMIA
    KASPERS, GJL
    VEERMAN, AJP
    PIETERS, R
    VANZANTWIJK, I
    KLUMPER, E
    HAHLEN, K
    DEWAAL, FC
    VANWERING, ER
    LEUKEMIA, 1994, 8 (01) : 24 - 29
  • [10] Administration Schedule of Daunorubicin for Elderly Patients with Acute Myelogenous Leukemia: A Single-institute Experience
    Dobashi, Nobuaki
    Usui, Noriko
    Yano, Shingo
    Yahagi, Yuichi
    Takei, Yutaka
    Sugiyama, Katsuki
    Takahara, Shinobu
    Ogasawara, Yoji
    Yamaguchi, Yuko
    Saito, Takeshi
    Yokoyama, Hiroki
    Aiba, Keisuke
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (06) : 820 - 824
12345